Condition: Acute-On-Chronic Liver Failure · Sponsor: Beijing 302 Hospital
This study is a randomized double-blind placebo-controlled multicenter clinical trial to evaluate the safety and efficacy of human umbilical cord mesenchymal stem cell (UC-MSC) transplantation for the treatment of acute-on-chronic liver failure (ACLF). UC-MSC therapy may improve the clinical outcomes of patients with ACLF. The trial would provide scientific evidence for UC-MSC transplantation as a potential treatment for ACLF.
This description comes directly from the study's public registry record.
Tao Yang, MD · 86-010-66933333 · y_t_0321@163.com
Yanhu Wang, MM · 86-010-66933328 · 2440477984@qq.com
Always discuss trial participation with your own doctor first.
| the Fifth Medical Center, Chinese PLA General Hospital | Beijing, Beijing Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05985863